FindMyKOL
Clinical trialNCT04311502TerminatedPhase 2Interventional

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment104HIVTuberculosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study was to compare a 3-month rifapentine (RPT)/clofazimine (CFZ)-containing regimen with a CFZ loading dose with the 6-month standard of care (SOC) regimen for drug-susceptible (DS) tuberculosis (TB).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Haiti
  • Les Centres Gheskio Clinical Research Site (gheskio-Inlr) Crs

    Port-au-Prince, Haiti

India
  • Byramjee Jeejeebhoy Medical College (bjmc) Crs

    Pune, India

Malawi
  • Malawi Crs

    Lilongwe, Central Region, Malawi

  • Blantyre Crs

    Blantyre, Malawi

South Africa
  • Caprisa Ethekwini Crs

    Durban, KwaZulu-Natal, South Africa

Zimbabwe
  • Milton Park Crs

    Harare, Zimbabwe

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Nov 2021
Primary completion
24 Jun 2024
Completion
24 Jun 2025
Last update posted
8 Jul 2026
Registered enrollment
104
Registry id
NCT04311502

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.